Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Medical simulation is also expressed as technique which is comprised of training and feedback for easy learning of task and processes under realistic settings and circumstances by use of advanced tools and models like virtual reality. It uses feedback from observers such as professors, peers, patients and video cameras. Simulation in healthcare industries is used for mimicking most of the essential aspects for better understanding. Additionally, it also helps in situation management which can occur in real medical practise. As the advancement of technology in communication, science and education, the healthcare professionals re able to simulate very detailed procedures in order to train the learners in a effective and safe environment.
The Asia Pacific medical simulation market is witnessing lucrative growth during the forecast period of 2021 to 2027. The growing concern about safety in healthcare industry along with increased mortality rate due to medical errors is gaining market attention of Asia Pacific medical simulation market. The dynamic factors such as necessity to improve patient safety is propelling growth of Asia Pacific medical simulation market. The benefit of training of complex and normal cases is also refuelling growth of Asia Pacific medical simulation market. Furthermore, adoption of advanced technology in healthcare industries is also boosting growth of Asia Pacific medical simulation market. However, high installation cost of medical simulation is hampering the growth of Asia Pacific medical simulation market.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the medical simulation market. In addition, complete analysis of changes on medical simulation expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Asia Pacific economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The rising prevalence of COVID-19 in many countries is the key factor propelling growth of medical simulation market. Also, the necessity to maintain social distancing as preventive measure against the COVID-19 is refuelling growth of healthcare IT industries. Likewise, need for digitalization in healthcare field is boosting the growth of healthcare IT solutions. The COVID-19 pandemic situation has increased the surge to use internet as many people are working from home, which is impacting positively on the medical simulation market.
The Asia Pacific medical simulation market is categorised by products and services, end user and country.
The Asia Pacific medical simulation market imparts the products and services such as patient simulator, task trainer, surgical simulator, dental simulator, eye simulator, ultrasound simulator and simulation software. The surgical simulator is sub-categorised into laparoscopic, gynaecology, cardiovascular, orthopaedic and spine. In which simulation software is also contributing in the growth of Asia Pacific medical simulation market. Simulation software is based on process of modelling a realistic phenomenon with a set of mathematical formulas. The simulation software imparts the exposure to realistic clinical challenges by means of task training, mannequins, virtual reality, standardized patients, in-situ approach and other hybrid forms. These makes them more demandable in the Asia Pacific medical simulation market.
The Asia Pacific medical simulation market comprised of end users such as academic institute, research centre, hospitals & clinics, military organization. In which military organization is also contributing in the growth of Asia Pacific medical simulation market. The medical simulation can provide realistic learning experience environment in medical skill training, from buddy-aid to trauma surgery procedures. This enhances limited hands-on training opportunities and revolutionize the way we train in peace for delivering medicines in war. These factors attributed the growth of Asia Pacific medical simulation market.
Country wise the Asia Pacific medical simulation market analysed the key countries such as India, China, Japan, Australia and South Korea. In which China followed by India and Japan are anticipated to dominate the market in 2020. The growing population is key factor that attributed growth of Asia Pacific medical simulation market. The growing cases of surgical errors is also boosting growth of Asia Pacific medical simulation market. The rising focus on patient safety is also propelling growth of Asia Pacific medical simulation market.
The key players in the market are Cae Inc., 3D Systems, Laerdal Medical, Gaumard Scientific Company, Kyoto Kagaku, Limbs & Things, Mentice Ab, Simulab Corporation, Intelligent Ultrasound Group Plc, Operative Experience Inc., Surgical Science Sweden Ab., Cardionics Inc., Virtamed Ag, Synbone Ag, Vrmagic Holding Ag., Ossimtech, Hrv Simulation, Synaptive Medical and Inovus Medical among others.
April 2020: CAE collaborated with Area9 Lyceum (US) to provide an online Ventilator Reskilling Course to the clinician's midst of the Covid-19 pandemic.
April 2020: 3D Systems launched Lung Ultrasound Training services to combat the current COVID-19 pandemic.
March 2020: CAE launched the Vimedix 3.0, a high-fidelity simulator that facilitates the learning process for cardiac, lung, Obs/Gyn, and stomach all in one through a common platform.
March 2020: 3D Systems collaborated with Ben Gurion University (Israel), and Beer- Sheva (Israel). The collaboration aimed to develop training modules that enable clinicians to acquire rapid and accurate lung diagnostic skills using an ultrasound machine and improve Covid-19 Triage.
The study comprises medical simulation market by product and services, end users and geography. The study also imparts dominating segments of the market. The product and services is dominated by the surgical simulation segment. Likewise, end user segment is dominated by surgical simulations. Geographically, China followed by India and Japan are anticipated to dominate the market in 2020. The study also analysed the impact of COVID-19 impact on medical simulation market. The rising prevalence of COVID-19 in many countries is the key factor propelling growth of medical simulation market. Also, the necessity to maintain social distancing as preventive measure against the COVID-19 is refuelling growth of healthcare IT industries. Likewise, need for digitalization in healthcare field is boosting the growth of healthcare IT solutions. The COVID-19 pandemic situation has increased the surge to use internet as many people are working from home, which is impacting positively on the medical simulation market. The study also analysed the various key players operating in the market.
Why to buy this report
